Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dina Sharon"'
Autor:
Donald A. Bergstrom, Hudson Brandi M, Kamil Bruderek, Schoenherr Heike, Moustakas Demetri T, Jessica Casaletto, Dina Sharon, Lindsey Foster, Roberto Valverde, Pelin Ayaz, Songping Zhao, Dejan Maglic, Alexander B. Taylor, B. Barry Toure, Patrick O'Hearn, Nastaran Gerami-Moayed, James M. Watters, Hakan Gunaydin
Publikováno v:
Cancer Research. 81:1455-1455
FGFR2 fusions, amplifications, and mutations are oncogenic drivers that occur across multiple tumor types. Clinical efficacy observed with pan-FGFR inhibitors has validated the driver status of FGFR2 in FGFR2 fusion-positive intrahepatic cholangiocar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c64dea51132c42e7abccbdcb28991e5a
https://doi.org/10.1158/1538-7445.am2021-1455
https://doi.org/10.1158/1538-7445.am2021-1455
Autor:
Juuli Raivola, Olli Silvennoinen, Henrik Hammaren, Pelin Ayaz, Yibing Shan, Dina Sharon, Stevan R. Hubbard, David E. Shaw
The protein JAK2 is a prototypical member of the Janus kinase family, and mediates signals from numerous cytokine receptors. The constitutively active V617F mutant of JAK2 is prevalent in many bone marrow disorders, blood cancers, and autoimmune dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365bbce773fccd19d99fc95bac0ea0b0
https://doi.org/10.1101/727727
https://doi.org/10.1101/727727
